Drug, which will be added to UK treatment guidelines, offers hope at a time of growing concern country’s health system could be overwhelmed.

A new study has given hope to those most seriously ill with COVID-19 as more patients are admitted to British hospitals with the disease [Andy Rain/EPA]

An arthritis drug has been found to reduce the risk of death for people with the most severe cases of COVID-19 by a quarter, if they are given the treatment within 24 hours of entering intensive care, a British study of treatments for the disease has found.

The REMAP-CAP clinical trial, led by Imperial College and funded by the UK government, found tocilizumab, which suppresses the immune system and has long been used

Read More At Article Source | Article Attribution